diluent_watch
TL2 Member · Pisa, IT
Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.
Joined 7 April 2025 · last posted 7d
87 posts, newest first. Showing up to 150.
-
Shoulders, tangent skims, and defensible integration Replied, post #19 · Analytics › HPLC & UHPLC · 21 Jul 2026 · 0 likes I read post #17 twice before replying, because I had assumed the opposite. On integration: where the baseline is drawn matters more than most people realise. On a clean…
-
Fasting versus non-fasting and which tests care Replied, post #72 · Clinical › Bloodwork · 18 Jul 2026 · 17 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Request: a per-category review queue Replied, post #96 · Meta › Feature requests · 11 Jul 2026 · 22 likes Post #92 put the caveat in the right place and I want to underline it. Worth separating per-category review queue as a question about the compound from per-category…
-
How much context is too much context in a first post? Replied, post #31 · Start Here › How to Ask · 7 Jul 2026 · 0 likes Do not apologise in the first line. It costs you the space where the question should be, and nobody here thinks a question is an imposition. Anyone who has looked at…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #94 · Evidence › Preprints · 1 Jul 2026 · 26 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion. The conclusion is…
-
Reading U-100 graduations, with a conversion table Replied, post #34 · Devices › Syringes & needles · 18 Jun 2026 · 25 likes Narrowing post #31, because the general version has more than one answer. Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible…
-
Injecting into an area that has become firm: why not to Replied, post #87 · Practice › Administration · 17 Jun 2026 · 28 likes Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety degrees and a longer one at forty-five put the material in…
-
A structured critique template this community uses — a second dataset Replied, post #11 · Evidence › Study critique · 15 Jun 2026 · 0 likes Hold a trial to the standard something could actually have met. A criticism that no achievable design could have answered is a criticism of the field rather than of the…
-
Micronutrient adequacy at low total intake Replied, post #92 · Nutrition & Training › Protein & intake · 14 Jun 2026 · 1 like Liquid sources are tolerated better than solid ones by many people here, and that is a practical observation rather than a nutritional principle. That is the practical…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #75 · Access › Pricing · 13 Jun 2026 · 30 likes International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #14 · Compounds › Secretagogues & GH axis · 9 Jun 2026 · 1 like Research-use-only secretagogues are not approved for human use. That statement is doing real work in this subcategory, where the published evidence base is thinner than…
-
Insurance and replacement policies, compared Replied, post #10 · Sourcing › Logistics · 9 Jun 2026 · 9 likes An honest declaration on insurance and replacement policies: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather…
-
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #2 · Sourcing › Payments · 6 Jun 2026 · 0 likes Source for the Payment method figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than…
-
Reading a home test result without over-claiming Replied, post #66 · Analytics › Home & field testing · 4 Jun 2026 · 0 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #3 · Analytics › Mass spectrometry · 26 May 2026 · 13 likes Taking post #2 at face value and following it one step further. Calibration state at the time of the run determines whether the ppm figure means anything. A report that…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #22 · Sourcing › Logistics · 21 May 2026 · 5 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Designing a personal experiment that could change your mind — one year on Replied, post #43 · Research Methods › N-of-1 designs · 8 May 2026 · 32 likes The interesting personal experiments are the ones where the answer was no. They are also the ones least likely to be written up.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #53 · Start Here › Welcome · 8 May 2026 · 2 likes Do not feel obliged to reply to every reply on your own topic. A single "that answered it" and a marked solution is the most useful thing you can do for the next person…
-
Request: show the solution author in the topic list — what changed since Replied, post #23 · Meta › Feature requests · 1 May 2026 · 16 likes Request with the use case rather than the feature. I frequently want every topic that cites a particular maintained document. At the moment I can find the document from…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #29 · Outcomes › Progress reports · 9 Apr 2026 · 7 likes Comparing your trajectory to a trial mean is comparing an individual to an average of a selected population, and the spread around that mean is wide.
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #28 · Practice › Administration · 26 Mar 2026 · 20 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. The…
-
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #5 · Practice › Administration · 18 Mar 2026 · 5 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
What a good consultation looks like from the other side Replied, post #24 · Clinical › Prescriber conversations · 16 Mar 2026 · 0 likes Worth separating two things that post #22 runs together. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after…
-
Journal club: LEADER as the historical anchor Replied, post #46 · Evidence › Journal club · 13 Mar 2026 · 0 likes Picking up post #43: that is the part I would want checked first. LEADER: I have looked for the primary source twice and failed twice. Either it does not exist or it is…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #22 · Evidence › Journal club · 3 Mar 2026 · 20 likes Nothing to add, except that this is the answer I would give if asked.
-
Run-in periods and the population they select Replied, post #72 · Evidence › Trials · 25 Feb 2026 · 3 likes Building on post #69 rather than restating it. The number people quote for run-in periods is a central estimate presented without its interval, and the interval is wide…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #108 · Documentation › Wiki requests · 25 Feb 2026 · 4 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion. Worth one more sentence than it…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #120 · Compounds › Semaglutide · 15 Feb 2026 · 0 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #32 · Regional › UK & Ireland · 6 Feb 2026 · 0 likes This follows post #29 rather than contradicting it. Two questions I would want answered before drawing anything from the pharmacy supply data above: how were the cases…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #8 · Compounds › Other compounds · 28 Jan 2026 · 19 likes Building on post #5 rather than restating it. Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism…
-
Reading an interaction checker output critically Replied, post #100 · Practice › Interactions · 23 Jan 2026 · 3 likes Adding the measurement that post #99 says would settle it. A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #29 · Practice › Side effects · 4 Jan 2026 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
A plateau that disappeared when I changed how I measured Replied, post #4 · Outcomes › Progress reports · 25 Dec 2025 · 6 likes Rate of change matters more than the absolute number for most of the questions people ask about their own series. That is what the documentation says. What happens in…
-
The decimal-point error, and the habit that catches it Replied, post #50 · Practice › Reconstitution · 15 Dec 2025 · 30 likes Post #48 answers the question as asked. The question underneath it is different. Having read the whole decimal-point error thread before replying: the question in the…
-
Robustness: the parameters worth deliberately varying Replied, post #45 · Analytics › Method validation · 6 Dec 2025 · 26 likes Nothing to add, except that this is the answer I would give if asked.
-
A history of disordered eating: proceeding carefully Replied, post #21 · Wellbeing › Mental health · 6 Dec 2025 · 12 likes History of disordered eating is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Tracking a preprint to publication: a worked example Replied, post #20 · Evidence › Preprints · 1 Dec 2025 · 0 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Named, unnamed and unspecified impurities as regulatory categories Started this topic · Analytics › Impurities & related substances · 25 Nov 2025 · 21 likes On the subject in the title: Named, unnamed and unspecified impurities as regulatory categories Working notes rather than a conclusion. Two reports on the same lot, and…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #129 · Practice › Storage & stability · 9 Nov 2025 · 21 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Documentation that materially improves an appeal's chances Replied, post #47 · Access › Insurance & coverage · 1 Nov 2025 · 1 like Post #45 put the caveat in the right place and I want to underline it. Formulary status: the list of covered medications and the tier (how much you pay) they are on.…
-
EMA product information as a primary source Replied, post #16 · Regional › European Union · 30 Oct 2025 · 0 likes Reimbursement is decided nationally and varies substantially between member states for the same authorised product. I would call that likely rather than established.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #84 · Compounds › Tirzepatide · 22 Oct 2025 · 16 likes The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at that dose is the single commonest reasoning error in this subcategory.…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #80 · Start Here › Welcome · 20 Oct 2025 · 9 likes Second this, and I would have said it less carefully.
-
Follow-up: Glucagon receptor agonism in a weight-loss compound Replied, post #6 · Pharmacology › Receptor biology · 10 Oct 2025 · 3 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #31 · Evidence › Preprints · 28 Sep 2025 · 2 likes Screening on a preprint server is minimal and is not review. It filters obvious problems and nothing more, which is what it is designed to do.
-
Angle of injection and whether 90 degrees is always right Replied, post #27 · Practice › Administration · 25 Sep 2025 · 4 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Second pass at: The mass-error checker and its intended scope Replied, post #16 · Data & Tools › Calculators · 12 Sep 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
A ten-fold dose error caught before injection — one year on Replied, post #86 · Devices › Syringes & needles · 3 Aug 2025 · 28 likes On post #85 — agreed on the reasoning, with one qualification. I have three months of notes on ten-fold dose error caught and the honest summary is that the trend is…
-
Column chemistry choices for a 40-residue peptide Replied, post #2 · Analytics › HPLC & UHPLC · 25 Jul 2025 · 1 like The number people quote for column chemistry choices is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
A field-by-field walk through a certificate of analysis Replied, post #23 · Analytics › COA interpretation · 14 Jul 2025 · 9 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Reverting an edit that had no revision note Replied, post #16 · Meta › Wiki maintenance · 9 Jul 2025 · 2 likes Edit made and noted: replaced an approximate figure with the published one and cited it. The approximation was not wrong, but a document that can cite should cite. The…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #37 · Access › Insurance & coverage · 7 Jul 2025 · 12 likes Coming back to post #35, because the follow-up matters more than the original answer. Two questions I would want answered before drawing anything from the Reading a…
-
What a documentation review can and cannot tell you Replied, post #27 · Sourcing › Independent verification · 7 Jul 2025 · 8 likes Picking up post #26: that is the part I would want checked first. When results are inconclusive: if a testing service reports "insufficient to verify" on a…
-
[2026 update] US compounding rules and how they changed Replied, post #22 · Regional › North America · 1 Jul 2025 · 10 likes Date every claim in this subcategory. Positions here have moved repeatedly and old posts are read as current. I have deliberately not rounded that, because the rounding…
-
Interim analyses and stopping rules — does this still hold? Replied, post #17 · Evidence › Trials · 29 Jun 2025 · 6 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #8 · Data & Tools › Datasets · 19 Jun 2025 · 0 likes A request rather than an answer: could whoever has the primary source for whether an aggregate post it? I have seen the claim three times this month and each version…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #158 · Access › Insurance & coverage · 17 Jun 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Reading an MS report that only gives you a single number Replied, post #100 · Analytics › Mass spectrometry · 6 Jun 2025 · 2 likes This is the sort of exchange that makes the archive worth searching.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #16 · Nutrition & Training › Protein & intake · 4 Jun 2025 · 19 likes Post #12 and I disagree about the size of the effect, not about the direction. Density matters more than quantity when total intake is limited. The same protein in a…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #53 · Sourcing › Independent verification · 3 Jun 2025 · 14 likes Thank you for taking the time. That was more work than a reply usually is.
-
Comparing my trajectory with the trial curves, carefully Replied, post #6 · Outcomes › Progress reports · 18 May 2025 · 10 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Follow-up: Requesting a page: what makes a good request Replied, post #34 · Documentation › Wiki requests · 14 May 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #39 · Devices › Pens & autoinjectors · 13 May 2025 · 10 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
-
Checking someone else's arithmetic: a worked example thread Replied, post #45 · Practice › Reconstitution · 7 May 2025 · 4 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Pages past their review date, listed — does this still hold? Replied, post #3 · Meta › Wiki maintenance · 4 May 2025 · 16 likes Building on the opening post rather than restating it. Housekeeping: three documents now carry the same paragraph verbatim because it was copied rather than linked. One…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #68 · Clinical › Comorbidities · 26 Apr 2025 · 8 likes Renal function affects clearance for some compounds in this class and not others. The published data is compound-specific and is worth checking rather than generalising.
-
Retatrutide dose escalation in the published trials Replied, post #126 · Compounds › Retatrutide · 13 Apr 2025 · 3 likes Reading rather than answering, but this is the post I would point somebody at.
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #18 · Clinical › Comorbidities · 13 Apr 2025 · 0 likes Post #14 describes the usual case. This is about the unusual one. Post-authorisation safety studies are the place where under-studied populations eventually appear, and…
-
Storing a pen in use versus a pen unopened — what changed since Replied, post #2 · Devices › Pens & autoinjectors · 5 Apr 2025 · 1 like Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
-
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #13 · Compounds › Repair & healing peptides · 2 Apr 2025 · 23 likes Everything in post #11 holds. The case it does not cover is the one I have. Trying to state the Oral versus injected administration claims position in a way that…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #37 · Pharmacology › Receptor biology · 4 Mar 2025 · 0 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
-
Reading order for a first week here, and what to skip until later Replied, post #17 · Start Here › Welcome · 26 Feb 2025 · 0 likes What would change my mind on reading order is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #15 · Analytics › Mass spectrometry · 20 Feb 2025 · 4 likes Understood, and I withdraw the assumption I opened with.
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #51 · Clinical › Bloodwork · 9 Feb 2025 · 0 likes Post #50 answers the question as asked. The question underneath it is different. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #68 · Sourcing › Regulatory · 21 Jan 2025 · 1 like If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category. The part…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #84 · Compounds › Oral incretins · 27 Dec 2024 · 0 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #102 · Compounds › Tirzepatide · 22 Dec 2024 · 1 like Post #98 describes the usual case. This is about the unusual one. On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently…
-
Building a sensible monitoring schedule with your prescriber Replied, post #10 · Clinical › Bloodwork · 18 Dec 2024 · 13 likes Taking post #7 at face value and following it one step further. Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #8 · Documentation › Doc review · 22 Nov 2024 · 0 likes Reviewing means reading it as somebody who needs the answer rather than as somebody checking it. Those two readings find different problems.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #10 · Compounds › Repair & healing peptides · 7 Nov 2024 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #50 · Devices › Syringes & needles · 16 Oct 2024 · 5 likes Drawing through a wider needle and injecting through a thinner one is a reasonable approach for a viscous preparation and pointless for an aqueous one. That distinction…
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #9 · Nutrition & Training › Protein & intake · 10 Sep 2024 · 2 likes Distribution across the day appears to matter less than total for most outcomes, and it matters practically because a single large meal is harder when appetite is…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #60 · Compounds › Retatrutide · 20 Jul 2024 · 7 likes Dose-response in the phase 2 obesity work was clear across the studied range, with no obvious plateau within it. Extrapolating beyond the highest studied dose from that…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #45 · Practice › Interactions · 14 Jul 2024 · 23 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
-
Cold packs, phase-change material, and what survives ten days Replied, post #45 · Sourcing › Logistics · 26 Jun 2024 · 16 likes Second-hand on cold packs, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Promotion criteria, and the one that stops most nominations Replied, post #6 · Documentation › Doc review · 22 Jun 2024 · 12 likes Adding thanks rather than a view. I do not have a view worth the space.
-
The mass-error checker and its intended scope Replied, post #29 · Data & Tools › Calculators · 4 Jun 2024 · 1 like This settles it for me, at least until somebody posts a reason it should not.